Skip to main content
. 2024 Aug 6;13(16):4594. doi: 10.3390/jcm13164594

Table 6.

Complication rates of each treatment method.

chTEVAR
% (N)
isfTEVAR
% (N)
cmfTEVAR
% (N)
cmbTEVAR
% (N)
Technical success 100 (5/5) 86 (6/7) 100 (6/6) 100 (3/3)
Endoleak 0 (0/5) 0 (0/7) 0 (0/6) 0 (0/3)
Reintervention 20 (1/5) 0 (0/7) 0 (0/6) 0 (0/3)
Stroke 0 (0/5) 27 (2/7) 0 (0/6) 0 (0/3)
major 0 (0/5) 14 (1/7) 0 (0/6) 0 (0/3)
minor 0 (0/5) 14 (1/7) 0 (0/6) 0 (0/3)
Myocardial infarction 0 (0/5) 0 (0/7) 0 (0/6) 0 (0/3)
Limb ischemia 0 (0/5) 0 (0/7) 0 (0/6) 0 (0/3)
Pseudoaneurysm 0 (0/5) 0 (0/7) 17 (1/6) 0 (0/3)
Acute kidney insufficiency requiring dialysis 20 (1/5) 0 (0/7) 0 (0/6) 0 (0/3)
Sepsis 20 (1/5) 0 (0/7) 0 (0/6) 0 (0/3)
Death 40 (2/5) 0 (0/7) 0 (0/6) 0 (0/3)

chTEVAR, chimney thoracic endovascular aortic repair. cmbTEVAR, custom-made branched thoracic endovascular aortic repair. cmfTEVAR, custom-made fenestrated thoracic endovascular repair. isfTEVAR, in situ fenestrated thoracic endovascular aortic repair.